Management of Narcotic-Induced Nausea

Initial Treatment Approach

• For patients receiving opioid analgesics, the American Society of Clinical Oncology recommends re-evaluating emetic risk, disease status, concurrent illnesses, and medications to ensure the best regimen is being used 1, 2

Breakthrough Nausea Management

• If nausea persists despite ondansetron, consider adding olanzapine (2.5-5 mg PO/sublingual every 6-8 hours), which has shown superior efficacy for breakthrough nausea 2, 3
• Metoclopramide (10-20 mg PO every 6 hours) offers both antiemetic and prokinetic effects, but should not be used if bowel obstruction is suspected 3
• Lorazepam or alprazolam may be beneficial for breakthrough nausea, especially if anxiety is contributing to nausea 2, 3

Special Patient Populations

• For patients with a history of severe opioid-induced nausea and vomiting, an individualized approach may be warranted, as recommended by the National Comprehensive Cancer Network 4
• For patients receiving highly emetogenic treatments, prophylactic antiemetic regimens are recommended, according to the American Society of Clinical Oncology 1, 5